Putting big pharma in charge of global vaccine rollout was a big mistake

Nick Dearden Covid has made it clear: the likes of Pfizer, in thrall to shareholders, only really care about their huge profits Tue 8 Feb 2022 Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year, making it easily the most lucrative medicine in any given year in history.